CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Kaya AI
United States
- Columbus, Ohio
- 23/01/2025
- Pre-Seed
- $5,300,000
At Kaya, we’re transforming the construction industry with smarter, faster, and more efficient solutions. Founded in 2022, Kaya is a supply chain intelligence platform powered by advanced AI and automation. Our mission is simple: help construction teams deliver projects on time, on budget, and with less hassle.
With Kaya, teams gain real-time insights, improved collaboration, and streamlined workflows, reducing delays and making every project a success. We’re not just solving today’s challenges – we’re building a future where construction works seamlessly and sustainably, in harmony with humanity and the planet.
Join us as we lead the way in smarter construction. Together, we can build a better future.
- Industry Software Development
- Website https://usekaya.ai/
- LinkedIn https://www.linkedin.com/company/usekayaai/
Related People
Ojonimi BakoFounder
United States -
New York, New York
Entrepreneurial Technology leader and Angel Investor with over 15 years of professional experience driving technology innovation and strategy with fortune 500 companies across Retail, eCommerce, Financial services, Non-government Organizations, and Health Care. Over the years, Ojonimi has become known for his role as an active angel investor, making strategic investments in early-stage AI and eCommerce startups. He also serves as a Limited Partner at two VC firms. In addition he has given keynote presentations several CIO Forums, appeared in TechCrunch, PCMag, and Engadget.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)